We report on structural, magnetic and electrical properties of Sr-doped LaMnO3 single crystals for doping levels 0.4 ≤ x ≤ 0.85. The complex structural and magnetic phase diagram can only be explained assuming significant contributions from the orbital degrees of freedom. Close to x = 0.6 a ferromagnetic metal is followed by an antiferromagnetic metallic phase below 200 K. This antiferromagnetic metallic phase exists in a monoclinic crystallographic structure. Following theoretical predictions this metallic antiferromagnet is expected to reveal an (x 2 -y 2 )-type orbital order. For higher Sr concentrations an antiferromagnetic insulator is established below room temperature.
X-ray diffraction, magnetic susceptibility, electron-spin resonance, and heat-capacity investigations were performed on MAl 2 O 4 compounds with M = Co, Fe, Mn, and Zn. All compounds crystallize in cubic spinel structure AB 2 O 4 with minor inversion between A and B sites. CoAl 2 O 4 and FeAl 2 O 4 reveal spin-glass-like ground states with freezing temperatures well below the Curie-Weiss temperatures indicating strong geometric frustration. Below the freezing temperatures, the heat capacities show a T 2 temperature dependence for T → 0 K as has recently been observed in some related geometrically frustrated magnets, in contrast to the linear dependence expected for common spin glasses. The heat capacity of FeAl 2 O 4 exhibits an additional orbital contribution. With the absence of a cooperative Jahn-Teller distortion, this points toward an orbital freezing. MnAl 2 O 4 orders antiferromagnetically below T N = 40 K with a reduced value of the ordered moment and a large paramagnetic component.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.